Save time and get answers to complex questions with AI chat
Bortezomib market france?Abbvie humira patent cliff navigation success?Patent tenofovir alafenamide gilead?Zemdri nce gain exclusivity 2028 patent 2031?Cost promethazine price?
See the DrugPatentWatch profile for Pifeltro
Pifeltro is the brand name for doravirine, an antiretroviral medicine used to treat HIV-1 infection. It is taken as part of combination antiretroviral therapy rather than by itself.
Doravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). NNRTIs work by binding to HIV reverse transcriptase and blocking the virus from copying its genetic material.
Pifeltro is used with other antiretroviral drugs as prescribed. The exact regimen depends on factors like prior HIV treatment history and resistance testing, since HIV that is already resistant to drugs in the regimen may not respond well.
For up-to-date patent and exclusivity tracking related to doravirine (Pifeltro), you can check DrugPatentWatch.com: DrugPatentWatch.com search for doravirine / Pifeltro.
Other Questions About Pifeltro :